Internal Medicine Doctors in Fairless Hills, PA Accepting Medicare

6 Internal Medicine doctors found. Showing 1 - 6

Dr. Evelyn Rosario Runer, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 333 N. Oxford Valley Rd., Suite 404, Fairless Hills, PA 19030 Phone: 215-741-4016    Fax: 215-741-4019

John E Moskaitis, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 N Oxford Valley Rd, Suite 107, Fairless Hills, PA 19030 Phone: 215-949-0100    Fax: 215-949-1600

Dr. Jeffrey Ray Blumenthal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 N Oxford Valley Rd, Ste 201, Fairless Hills, PA 19030 Phone: 215-946-1500    Fax: 215-946-3417

Ronny E Antelo, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 333 North Oxford Valley Road, Suite 503, Fairless Hills, PA 19030 Phone: 215-949-7925    Fax: 215-943-1304

Dr. Lewis Dunn, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 605 S Queen Anne Dr, Fairless Hills, PA 19030 Phone: 215-949-2550    Fax: 215-949-1012

Dr. Aubrey Marie Moyer, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 100 Lincoln Hwy, Fairless Hills, PA 19030 Phone: 267-587-0775

News Archive

Trius prices 10,000,000 shares initial public offering

Trius Therapeutics, Inc., a biopharmaceutical company developing innovative antibiotics for serious, life-threatening infections, announced today the initial public offering of 10,000,000 shares of its common stock at a price of $5.00 per share. The common stock is expected to begin trading on the NASDAQ Global Market on August 3, 2010 under the trading symbol "TSRX." Trius has granted the underwriters a 45 day option to purchase up to 750,000 shares of its common stock at the initial public offering price to cover over-allotments, if any.

Cataloguing microbes in gut could lead to cause of necrotizing enterocolitis

Scientists have for the first time sequenced and reconstructed the genomes of most of the microbes in the gut of a premature newborn and documented how the microbe populations changed over time.

Opinions: AIDS vaccine and cure; China's role in the Global Fund; Child marriage prevention act; Gorbachev on safe water

A Globe and Mail editorial discusses the importance of "the quest for an AIDS vaccine and the search for a cure," stating that "it is simply not possible to 'treat' our way out of this disease." The authors write that "for every person who receives treatment - which must continue over their entire lifetime - about three new people become infected."

A new promising target for broad-spectrum therapeutics against coronaviruses

A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.

Clontech launches new SMARTer Ultra Low RNA Kit

Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of its SMARTer Ultra Low RNA Kit for Illumina Sequencing, which was developed in collaboration with Illumina, Inc.

Read more Medical News

› Verified 6 days ago